Profound Medical Corp. (PROF)

Price$6.89Cached quote
PROFNasdaq
Loading local price history

Financial charts

Revenue

Total cash / debt

CashTotal debt

Financial statements

8 annual periodsNewest to oldest
20252024202320222021202020192018
Revenue$16.1M$9.7M$5.9M$6.7M$6.9M$7.3M$4.2M—
Gross profit$11.4M$7.0M$4.3M$3.0M$3.0M$3.5M$2.4M—
Gross margin70.77%72.25%73.10%45.22%42.95%47.56%57.26%—
Research & development$20.6M$17.0M$14.4M$14.7M$15.3M$9.9M$9.4M—
Operating expenses$52.6M$40.1M$33.0M$35.1M$33.2M$22.3M$17.3M—
Operating income−$41.3M−$33.1M−$28.7M−$32.1M−$30.3M−$18.9M−$14.9M—
Operating margin−256.27%−339.45%−485.69%−480.86%−440.72%−258.26%−357.07%—
EBITDA−$40.7M−$32.1M−$27.5M−$30.5M−$28.4M−$17.3M−$13.4M—
EBITDA margin−252.79%−329.84%−466.27%−456.85%−413.39%−237.20%−320.87%—
Net income−$42.6M−$27.8M−$28.3M−$28.7M−$30.7M−$21.6M−$15.2M—
Net profit margin−264.44%−285.59%−480.13%−429.11%−446.66%−296.03%−364.69%—
Basic EPSper basic share$1.41$1.12$1.34$1.38$1.50$1.25$1.37—
Diluted EPSper diluted share$1.41$1.12$1.34$1.38$1.50$1.25$1.37—

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 1 reported holders of PROF
HolderShares held
Menawat Arun Swarup
587.09K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys2$100.2K disclosed value
Sells (SEC code S)0$0.00 disclosed value
2 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 16, 2025Form 4Menawat Arun SwarupCEOBuyCommon Shares12.0K$4.73$56.9K587.1K
May 15, 2025Form 4Menawat Arun SwarupCEOBuyCommon Shares10.0K$4.33$43.3K575.1K

Community posts

It’s quiet here.

No posts about PROF yet. Start the conversation.

Write the first post